This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Chemed Shareholders Seeking To Recover Losses Through Investor Lawsuit Encouraged To Contact Securities Lawyers At Deans & Lyons LLP

DALLAS, May 30, 2013 /PRNewswire/ -- Securities lawyers are investigating Chemed (NYSE: CHE) due to potential violations of shareholder protection laws. Concerned CHE stockholders who seek to recover value for their shares should contact securities lawyer Hamilton Lindley at 877-819-8033 or hlindley@deanslyons.com about potential investor claims.

Securities lawyers are investigating the company due to a False Claims Act complaint filed by the U.S. Government.  The allegations in that lawsuit involve billing Medicare for unnecessary crisis care services and admitting patients who were not eligible for the Medicare hospice benefit.  On news of this lawsuit, Chemed stock price dropped precipitously.

Deans & Lyons LLP has significant experience representing investors in securities class action and derivative lawsuits nationwide.  Stockholders with concerns about their CHE stock or anyone with information about this situation should contact Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033.

Hamilton LindleyDeans & Lyons LLP 325 N. Saint Paul Street, Suite 1500 Dallas, TX 75201 (877) 819-8033 Toll Free (214) 965-8500 Telephone (214) 965-8505 Facsimile hlindley@deanslyons.com deanslyons.com

SOURCE Deans & Lyons LLP

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs